Neuroproteomics in neurotrauma

Neurotrauma in the form of traumatic brain injury (TBI) afflicts more Americans annually than Alzheimer's and Parkinson's disease combined, yet few researchers have used neuroproteomics to investigate the underlying complex molecular events that exacerbate TBI. Discussed in this review is...

Full description

Saved in:
Bibliographic Details
Published inMass spectrometry reviews Vol. 25; no. 3; pp. 380 - 408
Main Authors Ottens, Andrew K., Kobeissy, Firas H., Golden, Erin C., Zhang, Zhiqun, Haskins, William E., Chen, Su-Shing, Hayes, Ronald L., Wang, Kevin K.W., Denslow, Nancy D.
Format Journal Article
LanguageEnglish
Published Hoboken Wiley Subscription Services, Inc., A Wiley Company 01.05.2006
Wiley
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Neurotrauma in the form of traumatic brain injury (TBI) afflicts more Americans annually than Alzheimer's and Parkinson's disease combined, yet few researchers have used neuroproteomics to investigate the underlying complex molecular events that exacerbate TBI. Discussed in this review is the methodology needed to explore the neurotrauma proteome—from the types of samples used to the mass spectrometry identification and quantification techniques available. This neuroproteomics survey presents a framework for large‐scale protein research in neurotrauma, as applied for immediate TBI biomarker discovery and the far‐reaching systems biology understanding of how the brain responds to trauma. Ultimately, knowledge attained through neuroproteomics could lead to clinical diagnostics and therapeutics to lessen the burden of neurotrauma on society. © 2006 Wiley Periodicals, Inc., Mass Spec Rev 25:380–408, 2006
Bibliography:istex:4CC7FCD6E97DACB4AE34448B28288D23B9C34F88
ark:/67375/WNG-GZX587QB-Q
ArticleID:MAS20073
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-3
ObjectType-Review-1
ISSN:0277-7037
1098-2787
DOI:10.1002/mas.20073